It may actually becoma a longer term player the way the demographics of hospital expenditures is being directed by gub towards that end to this point the thing that matters are the patents,nobody seems to notice that we have have recently added to that portfolio and the patents also represent a large Trump card in that the projected molecular diagnosis market is 7.1 Billion US dollars That' on the books s a lot of black